Literature DB >> 2143171

Generation of alloreactive cytolytic T lymphocytes by immobilized anti-CD3 monoclonal antibodies. Analysis of requirements for human cytolytic T-lymphocyte differentiation.

R De Jong1, M Brouwer, V I Rebel, G A Van Seventer, F Miedema, R A Van Lier.   

Abstract

Requirements for the induction of human cytolytic T-lymphocyte (CTL) activity were studied in a monocyte-free T-cell activation system that uses immobilized anti-CD3 monoclonal antibodies (mAb) as a stimulus. Alloreactive CTL with specificity for HLA-A and -B locus antigens could be demonstrated within 2 days after the initiation of activation. CTL induction in purified T cells initiated by an optimal concentration of immobilized anti-CD3 mAb was not enhanced by the addition of monocytes or exogeneous cytokines, whereas addition of anti-CD25 mAb largely blocked the response. Upon suboptimal anti-CD3 mAb stimulation, addition of recombinant interleukin (rIL)-2, rIL-1 and rIL-4, but not recombinant interferon-gamma (IFN-gamma) or rIL-6, potentiated the development of CTL activity. Finally it was shown that immobilized anti-CD3 mAb induced significant levels of CTL activity in both purified CD4+ and CD8+ cells. This study indicates that the requirement for cytokines in the differentiation of CTL precursors depends on the strength of the activation signal delivered through the T-cell receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143171      PMCID: PMC1384166     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  Signal requirements in the step-wise functional maturation of cytotoxic T lymphocytes.

Authors:  G Gromo; R L Geller; L Inverardi; F H Bach
Journal:  Nature       Date:  1987 Jun 4-10       Impact factor: 49.962

2.  Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems.

Authors:  R A Van Lier; J H Boot; E R De Groot; L A Aarden
Journal:  Eur J Immunol       Date:  1987-11       Impact factor: 5.532

3.  Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by epsilon-anti-CD3.

Authors:  R A van Lier; J H Boot; A J Verhoeven; E R de Groot; M Brouwer; L A Aarden
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

4.  Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3.

Authors:  G Jung; D E Martin; H J Müller-Eberhard
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

5.  Molecular cloning and expression of hybridoma growth factor in Escherichia coli.

Authors:  J P Brakenhoff; E R de Groot; R F Evers; H Pannekoek; L A Aarden
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

6.  Identification of a 24-kDa cytokine that is required for development of cytolytic T lymphocytes.

Authors:  C Cernetti; R M Steinman; A Granelli-Piperno
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor.

Authors:  M B Widmer; K H Grabstein
Journal:  Nature       Date:  1987 Apr 23-29       Impact factor: 49.962

8.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

Authors:  Y Takai; G G Wong; S C Clark; S J Burakoff; S H Herrmann
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

9.  Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).

Authors:  M B Widmer; R B Acres; H M Sassenfeld; K H Grabstein
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  B cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.

Authors:  J D Pfeifer; D T McKenzie; S L Swain; R W Dutton
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  10 in total

1.  Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.

Authors:  R de Jong; P Stokkers; E Lamme; J M Kool; F Borst; M Brouwer; F Miedema; R A van Lier
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

2.  Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies.

Authors:  E W Nijhuis; E vd Wiel-van Kemenade; C G Figdor; R A van Lier
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  CD8⁺ T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung.

Authors:  Berber Piet; Godelieve J de Bree; Barbara S Smids-Dierdorp; Chris M van der Loos; Ester B M Remmerswaal; Jan H von der Thüsen; Jan M W van Haarst; Jan P Eerenberg; Anja ten Brinke; Wim van der Bij; Wim Timens; René A W van Lier; René E Jonkers
Journal:  J Clin Invest       Date:  2011-05-02       Impact factor: 14.808

4.  Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Authors:  David A Horwitz; Stephanie Pan; Jing-Ni Ou; Julie Wang; Maogen Chen; J Dixon Gray; Song Guo Zheng
Journal:  Clin Immunol       Date:  2013-08-20       Impact factor: 3.969

5.  Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulation with combined CD3 and CD28 monoclonal antibodies.

Authors:  M J Flens; W M Mulder; H Bril; M B von Blomberg van de Flier; R J Scheper; R A van Lier
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

6.  Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro.

Authors:  G Palladino; P A Scherle; W Gerhard
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose.

Authors:  P A Palmer; J G Scharenberg; B M von Blomberg; A G Stam; C J Meijer; G J Roest; C R Franks; R J Scheper
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

8.  Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein.

Authors:  B Hardy; M Galli; E Rivlin; L Goren; A Novogrodsky
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

9.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

10.  Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.

Authors:  B J Kroesen; J Buter; D T Sleijfer; R A Janssen; W T van der Graaf; T H The; L de Leij; N H Mulder
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.